- Home
- BRT vs HUMA Comparison
BRT vs HUMA Comparison
Compare BRT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRT | HUMA |
|---|---|---|
| Founded | 1972 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.9M | 236.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BRT | HUMA |
|---|---|---|
| Price | $14.91 | $1.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $19.75 | $10.13 |
| AVG Volume (30 Days) | 96.2K | ★ 4.3M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | ★ 6.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $98,001,000.00 | $1,571,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.72 | $731.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.30 | N/A |
| 52 Week Low | $14.00 | $1.09 |
| 52 Week High | $19.30 | $6.77 |
Technical Indicators
Market Signals| Indicator | BRT | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 53.97 | 40.33 |
| Support Level | $14.45 | $1.21 |
| Resistance Level | $15.15 | $1.32 |
| Average True Range (ATR) | 0.31 | 0.07 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 72.50 | 5.32 |
Price Performance
Historical ComparisonAbout BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.